A client taking extended-release theophylline develops new s… | MyMerci
MyMerci — full questions and rationale, free Start for free
Medication Administration PPT
Question

A client taking extended-release theophylline develops new symptoms. Which cluster is most concerning for theophylline toxicity?

Explanation
Theophylline has a narrow therapeutic index. Persistent vomiting, tachycardia or cardiac arrhythmias, agitation, and seizures are concerning for toxicity and can be life-threatening. The nurse should hold further doses as directed, obtain urgent clinical evaluation, and anticipate a serum theophylline concentration and cardiac monitoring. The other clusters fit opioid toxicity, severe hypothyroidism, or anaphylaxis rather than theophylline toxicity.
Next question on this topicBefore giving a scheduled dose of digoxin, the nurse obtains an apical pulse of 54/min in …

In-depth explanation

Clinical reasoning
Theophylline toxicity often begins with gastrointestinal and stimulant-like symptoms and can progress to dangerous tachyarrhythmias and intractable seizures.

Decision rule
Persistent vomiting, rapid heartbeat, or neurologic excitation during theophylline therapy requires prompt serum-level and cardiac evaluation.

Clinical scenario

Scenario 65-year-old male on theophylline 300 mg PO BID for COPD × 1 year. Trough level today: 22 mcg/mL (therapeutic 10-20). Reports new nausea and tremor.

Key concepts

Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free
Read in another language: English한국어日本語繁體中文Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.